Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/23/24 18:55 | 5/21/24 | EXEL | Health | BioPrd | Biological Products, (No Diag | Smith Julie | CA | D | 1 | S | -576 | 21.12 | 0 | -27 | 5 | D | ||||||||||||||||
5/22/24 19:23 | 5/21/24 | EXEL | Health | BioPrd | Biological Products, (No Diag | Poste George | CA | D | 1 | S.d | -245 | 20.96 | 0 | -12 | 214 | D | ||||||||||||||||
5/22/24 19:23 | 5/20/24 | EXEL | Health | BioPrd | Biological Products, (No Diag | Papadopoulos Stelios | CA | D | 1 | S.d | -240 | 21.00 | 0 | -11 | 1,261 | D | ||||||||||||||||
5/15/24 19:44 | 5/13/24 | EXEL | Health | BioPrd | Biological Products, (No Diag | Wyszomierski Jack L | CA | D | 1 | S.d | -233 | 21.37 | 0 | -11 | 339 | D | ||||||||||||||||
3/25/24 19:31 | 3/21/24 | EXEL | Health | BioPrd | Biological Products, (No Diag | Garber Alan M | CA | D | 1 | S.d | -461 | 24.01 | 0 | -19 | 36 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |